MetaADEDB 2.0 @ LMMD
Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination
(VERWQPYQDXWOGT-LVJNJWHOSA-N)
Structure
SMILES
Nc1nc(=O)n(cc1F)[C@@H]1CS[C@@H](O1)CO.C[C@H](Cn1cnc2c1ncnc2N)OCP(=O)(OCOC(=O)OC(C)C)OCOC(=O)OC(C)C.OC(=O)/C=C/C(=O)O
Molecular Formula:
C31H44FN8O17PS
Molecular Weight:
882.762
Log P:
3.4548
Hydrogen Bond Acceptor:
26
Hydrogen Bond Donor:
5
TPSA:
385.52
CAS Number(s):
731772-45-5
Synonym(s)
1.
Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination
2.
Emtricitabine Tenofovir Disoproxil Fumarate Drug Combination
3.
Emtricitabine-Tenofovir Disoproxil Fumarate Drug Combination
4.
Truvada
External Link(s)
MeSHD000069480
PubChem Compound11954236
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Adverse eventFAERS: 7US FAERS
2PneumoniaFAERS: 4US FAERS
3StillbirthFAERS: 4US FAERS
4AnxietyFAERS: 3US FAERS
5NauseaFAERS: 3US FAERS
6Acute HIV infectionFAERS: 2US FAERS
7AppendicitisFAERS: 2US FAERS
8Chest PainFAERS: 2US FAERS
9GastroenteritisFAERS: 2US FAERS
10Musculoskeletal chest painFAERS: 2US FAERS
11SepsisFAERS: 2US FAERS
12Suicide attemptFAERS: 2US FAERS
13Trisomy 21FAERS: 2US FAERS
14Umbilical herniaFAERS: 2US FAERS
15Abdominal PainFAERS: 1US FAERS
16Acute hepatitis CFAERS: 1US FAERS
17Acute kidney injuryFAERS: 1US FAERS
18Alanine Aminotransferase IncreasedFAERS: 1US FAERS
19Anal FistulaFAERS: 1US FAERS
20Anal abscessFAERS: 1US FAERS
21Ankle FractureFAERS: 1US FAERS
22Arthropod stingFAERS: 1US FAERS
23AscitesFAERS: 1US FAERS
24Autoimmune hepatitisFAERS: 1US FAERS
25Bipolar I disorderFAERS: 1US FAERS
26Cerebrovascular accidentFAERS: 1US FAERS
27ChromaturiaFAERS: 1US FAERS
28DisabilityFAERS: 1US FAERS
29DiverticulitisFAERS: 1US FAERS
30Drug dose omissionFAERS: 1US FAERS
31Drug ineffectiveFAERS: 1US FAERS
32Drug resistanceFAERS: 1US FAERS
33Ectopic PregnancyFAERS: 1US FAERS
34FractureFAERS: 1US FAERS
35HeadacheFAERS: 1US FAERS
36Hepatitis BFAERS: 119731560CTD
US FAERS
37Hepatitis CFAERS: 1US FAERS
38Hepatitis syphiliticFAERS: 1US FAERS
39HepatitisFAERS: 1US FAERS
40HepatotoxicityFAERS: 1US FAERS
41HypotensionFAERS: 1US FAERS
42MalariaFAERS: 1US FAERS
43NephrolithiasisFAERS: 1US FAERS
44NeurosyphilisFAERS: 1US FAERS
45PalpitationsFAERS: 1US FAERS
46PhotophobiaFAERS: 1US FAERS
47PneumothoraxFAERS: 1US FAERS
48PoisoningFAERS: 1US FAERS
49Pre-EclampsiaFAERS: 1US FAERS
50Prescription drug used without a prescriptionFAERS: 1US FAERS
51Pulmonary EmbolismFAERS: 1US FAERS
52Renal Artery StenosisFAERS: 1US FAERS
53Skin lesionFAERS: 1US FAERS
54SyndactylyFAERS: 1US FAERS
55TalipesFAERS: 1US FAERS
56TinnitusFAERS: 1US FAERS
57Transaminases increasedFAERS: 1US FAERS
58Treponema test positiveFAERS: 1US FAERS
59Urinary tract infectionFAERS: 1US FAERS
60VasculitisFAERS: 1US FAERS
61VertigoFAERS: 1US FAERS
62Virologic failureFAERS: 1US FAERS
63jaundiceFAERS: 1US FAERS
64HIV Infections19731560CTD
65Hyperpigmentation18156608CTD
66Neurologic Manifestations18156608CTD
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120239

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.